Fiona Simpkins

3.9k total citations
111 papers, 2.4k citations indexed

About

Fiona Simpkins is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Fiona Simpkins has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 38 papers in Reproductive Medicine and 37 papers in Molecular Biology. Recurrent topics in Fiona Simpkins's work include Ovarian cancer diagnosis and treatment (36 papers), PARP inhibition in cancer therapy (28 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Fiona Simpkins is often cited by papers focused on Ovarian cancer diagnosis and treatment (36 papers), PARP inhibition in cancer therapy (28 papers) and Endometrial and Cervical Cancer Treatments (17 papers). Fiona Simpkins collaborates with scholars based in United States, United Kingdom and Canada. Fiona Simpkins's co-authors include Barbara E. Swartz, Elise C. Kohn, Eric Halgren, Erin George, Joyce M. Slingerland, Rugang Zhang, Hyoung Kim, Mark A. Morgan, M. Gee and Eric J. Brown and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Fiona Simpkins

103 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Simpkins United States 29 1.1k 941 500 302 241 111 2.4k
Mikio Terauchi Japan 19 731 0.7× 945 1.0× 168 0.3× 123 0.4× 316 1.3× 29 1.8k
Sandra Lee United States 18 842 0.8× 294 0.3× 307 0.6× 245 0.8× 194 0.8× 41 1.9k
Károly Szepesházi United States 35 1.1k 1.0× 1.2k 1.3× 385 0.8× 39 0.1× 255 1.1× 96 3.1k
Felix Zeppernick Germany 17 609 0.6× 691 0.7× 343 0.7× 188 0.6× 384 1.6× 40 1.6k
Patricia Armatis United States 31 759 0.7× 839 0.9× 191 0.4× 52 0.2× 302 1.3× 49 2.4k
Monika Schindl Austria 23 1.4k 1.3× 760 0.8× 118 0.2× 213 0.7× 1.3k 5.3× 39 2.5k
Kate Lawrenson United States 27 1.0k 0.9× 486 0.5× 401 0.8× 159 0.5× 530 2.2× 62 1.9k
Mark A. Eckert United States 19 1.7k 1.6× 608 0.6× 266 0.5× 78 0.3× 798 3.3× 32 2.7k
Carla F.M. Molthoff Netherlands 32 664 0.6× 702 0.7× 84 0.2× 33 0.1× 287 1.2× 77 2.6k
Martin C. Chang Canada 24 1.1k 1.0× 731 0.8× 218 0.4× 112 0.4× 568 2.4× 67 2.2k

Countries citing papers authored by Fiona Simpkins

Since Specialization
Citations

This map shows the geographic impact of Fiona Simpkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Simpkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Simpkins more than expected).

Fields of papers citing papers by Fiona Simpkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Simpkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Simpkins. The network helps show where Fiona Simpkins may publish in the future.

Co-authorship network of co-authors of Fiona Simpkins

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Simpkins. A scholar is included among the top collaborators of Fiona Simpkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Simpkins. Fiona Simpkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ko, Emily, et al.. (2024). Disparities in gynecologic oncology clinical trial availability in the United States: A state-level analysis.. Journal of Clinical Oncology. 42(16_suppl). e23128–e23128.
2.
Pantel, Austin R., Sarah B. Gitto, Fang Liu, et al.. (2024). [18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status. Journal of Nuclear Medicine. 66(1). 34–39.
3.
Bauer, Todd M., Kathleen N. Moore, Janet S. Rader, et al.. (2023). A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted Oncology. 18(4). 517–530. 21 indexed citations
4.
Gitto, Sarah B., Gareth Davies, Sushil Kumar, et al.. (2023). A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression. Clinical Cancer Research. 30(8). 1567–1581. 16 indexed citations
5.
Wethington, Stephanie L., Payal D. Shah, Lainie P. Martin, et al.. (2023). C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer. Clinical Cancer Research. 29(15). 2800–2807. 40 indexed citations
6.
Smith, Anna Jo Bodurtha, Meredith Doherty, Stefanie N. Hinkle, et al.. (2023). Transportation assistance in gynecologic oncology: A pilot study.. JCO Oncology Practice. 19(11_suppl). 206–206. 1 indexed citations
7.
Smith, Anna Jo Bodurtha, et al.. (2023). Disparities in clinical trial participation in ovarian cancer: A real-world analysis. Gynecologic Oncology. 175. 25–31. 5 indexed citations
8.
Pierini, Stefano, János L. Tanyi, Fiona Simpkins, et al.. (2020). Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight. 5(16). 19 indexed citations
9.
Simpkins, Fiona. (2020). Brexit, Indyref2 and the 2019 General Election in Scotland. SHILAP Revista de lepidopterología. XXV(3). 1 indexed citations
10.
Simpkins, Fiona. (2019). Twenty Years of Devolution in Scotland: the End of a British Party System?. SHILAP Revista de lepidopterología. XXIV(4).
11.
Simpkins, Fiona, Kibeom Jang, Hyunho Yoon, et al.. (2018). Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells. Clinical Cancer Research. 24(19). 4874–4886. 57 indexed citations
12.
Simpkins, Fiona. (2017). The 2016 Scottish Parliament Elections: Unionist Parties and the Constitutional Divide. SHILAP Revista de lepidopterología. 22(4). 2 indexed citations
13.
Kim, Hyoung, Erin George, Ryan L. Ragland, et al.. (2016). Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA -Mutant Ovarian Cancer Models. Clinical Cancer Research. 23(12). 3097–3108. 234 indexed citations
14.
Miller, Philip C., Dorraya El‐Ashry, Jun Sun, et al.. (2015). MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 22(4). 935–947. 46 indexed citations
15.
Zhang, Xiaochen, Ashley Haggerty, Justin C. Brown, et al.. (2015). The prescription or proscription of exercise in endometrial cancer care. Gynecologic Oncology. 139(1). 155–159. 11 indexed citations
16.
Simpkins, Fiona. (2015). Better Together and the No Campaign: from Project Fear to Grace?. SHILAP Revista de lepidopterología. 20(2).
17.
Simpkins, Fiona, Aurea E. Flores, Christina Chu, et al.. (2013). Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study. Cancer Immunology Research. 1(3). 168–178. 41 indexed citations
18.
Simpkins, Fiona, Jun Sun, Candace A. Gilbert, et al.. (2012). Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo. Clinical Cancer Research. 18(21). 5911–5923. 54 indexed citations
19.
Kunos, Charles A., Fiona Simpkins, Heidi Gibbons, Chunqiao Tian, & Howard D. Homesley. (2009). Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar Cancer. Obstetrics and Gynecology. 114(3). 537–546. 121 indexed citations
20.
Bristow, Robert E., Fiona Simpkins, Harpreet K. Pannu, Elliot K. Fishman, & F.J. Montz. (2002). Positron Emission Tomography for Detecting Clinically Occult Surgically Resectable Metastatic Ovarian Cancer. Gynecologic Oncology. 85(1). 196–200. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikio Terauchi Breakdown of academic impact, for papers by Sandra Lee Breakdown of academic impact, for papers by Károly Szepesházi Breakdown of academic impact, for papers by Felix Zeppernick Breakdown of academic impact, for papers by Patricia Armatis Breakdown of academic impact, for papers by Monika Schindl Breakdown of academic impact, for papers by Kate Lawrenson Breakdown of academic impact, for papers by Mark A. Eckert Breakdown of academic impact, for papers by Carla F.M. Molthoff Breakdown of academic impact, for papers by Martin C. Chang
Rankless by CCL
2026